At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,377 enrolled
Drug / intervention
PrEP acronym (pre-exposure prophylaxis)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare
In Brief
An observational study evaluating PrEP acronym (pre-exposure prophylaxis) for PrEP Precriptions for Reproductive Aged Women. Completed, enrolled 1,377 participants across 1 site.
Detailed Summary
The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
202420252026
Enrollment StartSep 2023
Primary CompletionAug 2025
First PostedOct 2025
TodayJul 2026
First PostedOct 7, 2025
Enrollment StartSep 22, 2023
Primary CompletionAug 16, 2025
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9 months ago
Interventions
PrEP acronym (pre-exposure prophylaxis)behavioral
Tracked PrEP prescriptions over 8 months among patients who completed the survey